Clinical trials in Rho

Innovative clinical trials focusing on ovarian cancer treatments, particularly exploring maintenance therapies and novel approaches for recurrent cases.

• BRCA wild-type ovarian cancer studies
• Secondary cytoreductive surgery outcomes
• Maintenance therapy effectiveness

Research includes evaluation of Olaparib in different treatment scenarios for advanced and recurrent cases.

Comprehensive research into ulcerative colitis and Crohn's disease, evaluating new therapeutic approaches and long-term treatment options.

• Novel biological therapies
• Fistulizing perianal Crohn's treatment
• Long-term maintenance studies

Investigating medications like mirikizumab and risankizumab for improved disease management.

Advanced studies in metastatic colorectal cancer, focusing on personalized treatment approaches based on genetic profiles.

• RAS/BRAF mutation analysis
• First-line therapy comparisons
• Liquid biopsy applications

Evaluating combination therapies with bevacizumab and cetuximab for optimal treatment outcomes.